Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.08.19
关于使用逾额召募资金建设合资企业的通告
2011.08.19
第二届董事会第六次聚会决议通告
2011.08.19
关于使用逾额召募资金对控股子公司举行增资的通告
2011.08.19
中国建银投资证券有限责任公司关于公司有关逾额召募资金使用事项的核查意见
2011.08.19
关于办公场合迁址的通告
2011.08.19
第二届监事会第六次聚会决议通告
2011.08.19
2011年半年度财务报告
2011.07.30
中国建银投资证券有限责任公司关于公司相关逾额召募资金使用的核查意见
2011.07.30
第二届监事会第五次聚会决议通告
2011.07.30
关于签署《召募资金三方羁系协议之增补协议》的通告
第一页
上一页
136
137
138
139
140
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】